Teneligliptin Hydrobromide Intermediate CAS 401564-36-1 Ịdị ọcha> Ụlọ ọrụ 99.5% (HPLC)
Nnweta Teneligliptin Hydrobromide metụtara Intermediates na ịdị ọcha dị elu
Teneligliptin Hydrobromide CAS 906093-29-6
1- (3-Methyl-1-Phenyl-5-Pyrazolyl)piperazine CAS 401566-79-8
Teneligliptin Hydrobromide Intermediate CAS 401564-36-1
| Aha Chemical | (2S) -4-Oxo-2- (3-thiazolidinylcarbonyl) -1-pyrrolidinecarboxylic acid tert-butyl ester. |
| Ụdị okwu | (S) -tert-Butyl 4-oxo-2- (thiazolidine-3-carbonyl) pyrrolidine-1-carboxylate;3-((S) -1-tert-butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl) -1,3-thiazolidine;(2S) -4-oxo-2- (1,3-thiazolidin-3-ylcarbonyl) pyrrolidine-1-carboxylate;Teneliptin Intermediate B |
| Nọmba CAS | 401564-36-1 |
| Nọmba CAT | RF-1818 |
| Ọnọdụ Ahịa | N'ọkwa, Mpụta Ihe ruru Tọn |
| Usoro ihe omimi | C13H20N2O4S |
| Ibu molekụla | 300.37 |
| Njupụta | 1.305 |
| Ụdị | Ruifu Chemical |
| Ihe | Standardkpụrụ nyocha | Nsonaazụ |
| Ọdịdị | Ọcha ruo ude siri ike | Kwado |
| njirimara | IR;HPLC RT | Kwado |
| Ọnwụ na ihicha | <1.00% | 0.20% |
| Ihe ndị emetụtara | Otu adịghị ọcha <0.50% | 0.24% |
| Mkpokọta adịghị ọcha <0.50% | 0.39% | |
| Nyocha | 99.5% ~ 102.0% (Ọ dabere na akpọnwụwo) | 99.8% |
| Enantiomeric ịdị ọcha | > 99.5% | 99.9% |
| Sulfated Ash | <0.20% | 0.02% |
| Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ | |
| Ojiji | Ndị etiti nke Teneligliptin Hydrobromide (CAS: 906093-29-6) | |
ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri
(2S) -4-Oxo-2- (3-thiazolidinylcarbonyl) -1-pyrrolidinecarboxylic acid tert-butyl ester (CAS: 401564-36-1) bụ ihe dị n'etiti eji akwadebe dipeptidyl peptidase IV (DPP-IV) inhibitor, etiti etiti. nke Teneligliptin Hydrobromide (CAS: 906093-29-6).Teneligliptin bụ ihe mgbochi DPP-4 nke akwadoro na Japan na 2012 maka ọgwụgwọ ụdị ọrịa shuga II.Ọ bụ Mitsubishi Tanabe Pharma chọpụtara wee mepụta ya n'okpuru aha azụmaahịa Tenelia®.Dị ka ndị na-egbochi DPP-4 ndị ọzọ a na-ere ahịa, a nabatara Teneligliptin nke ọma na ọmụmụ ihe niile yana usoro QD na-emepụta ihe mgbochi na-adịte aka megide DPP-4 yana mmụba na ọkwa GLP-1 na-arụ ọrụ, yana ọnụ ọgụgụ dị ala nke excretion gbasara akụrụ.
